Abstract |
Our previous studies demonstrated that anti-CD40 mAb (anti-CD40) can synergize with CpG oligodeoxynucleotides (CpG) to mediate antitumor effects by activating myeloid cells, such as macrophages in tumor-bearing mice. Separate teams have shown that chemotherapy with gemcitabine (GEM) or 5-fluorouracil (5-FU) can reduce tumor-induced myeloid-derived suppressor cells (MDSC) in mice. In this study we asked if the same chemotherapy regimens with GEM or 5-FU will enhance the antitumor effect of anti-CD40 and CpG. Using the model of B16 melanoma growing intraperitoneally in syngeneic C57BL/6 mice, we show that these GEM or 5-FU treatment regimens reduced MDSC in the peritoneal cavity of tumor-bearing mice. Treatment of mice with GEM or 5-FU did not significantly affect the antitumor function of macrophages as assessed in vitro. In vivo, treatment with these GEM or 5-FU regimens followed by anti-CD40/CpG resulted in antitumor effects similar to those of anti-CD40/CpG in the absence of GEM or 5-FU. Likewise, reduction of MDSC by in vivo anti-Gr-1 mAb treatment did not significantly affect anti-CD40/CpG antitumor responses. Together, the results show that the GEM or 5-FU chemotherapy regimens did not substantially affect the antitumor effects induced by anti-CD40/CpG immunotherapy.
|
Authors | Xiaoyi Qu, Mildred A R Felder, Zulmarie Perez Horta, Paul M Sondel, Alexander L Rakhmilevich |
Journal | International immunopharmacology
(Int Immunopharmacol)
Vol. 17
Issue 4
Pg. 1141-7
(Dec 2013)
ISSN: 1878-1705 [Electronic] Netherlands |
PMID | 24201083
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Copyright | © 2013. |
Chemical References |
- Adjuvants, Immunologic
- Antimetabolites, Antineoplastic
- CD40 Antigens
- CPG-oligonucleotide
- Cancer Vaccines
- Nitrites
- Oligodeoxyribonucleotides
- Deoxycytidine
- Fluorouracil
- Gemcitabine
|
Topics |
- Adjuvants, Immunologic
(administration & dosage)
- Animals
- Antimetabolites, Antineoplastic
(administration & dosage)
- Antineoplastic Combined Chemotherapy Protocols
(administration & dosage)
- CD40 Antigens
(immunology)
- Cancer Vaccines
- Cell Line, Tumor
- Deoxycytidine
(administration & dosage, analogs & derivatives)
- Female
- Fluorouracil
(administration & dosage)
- Immunotherapy
- Macrophages
(drug effects, metabolism)
- Melanoma, Experimental
(metabolism, pathology, therapy)
- Mice
- Mice, Inbred C57BL
- Nitrites
(metabolism)
- Oligodeoxyribonucleotides
(administration & dosage, immunology)
- Skin Neoplasms
(metabolism, pathology, therapy)
- Tumor Burden
(drug effects)
- Gemcitabine
|